SUPPLEMENTARY RESULTS

I) Development and validation of SSV-Seq
To differentiate DNA outside and inside the viral capsid, we compared the ability of several DNases, to digest DNA fragments mixed with rAAV particles. Quantification of residual DNA after DNases treatment showed that the combination of the Baseline-ZERO endonuclease and the Plasmid-Safe exonuclease led to reduction of the amount of DNA exceeding 1x10 5 fold (Fig.S1 ). In parallel, the amount of rAAV genome was not affected by the treatment. In addition, for each sample analysed by SSV-Seq, a spike-in control consisting of exogenous DNA (Lambda phage DNA) was used to validate the efficiency of the DNAses treatment by analysing mapped reads after NGS (Table S5 ). Since the exact nature of the rAAV outer capsid and the DNA contaminant is not known, we do not exclude that our spike-in controls would not reproduce DNA strongly tighten to the capsid surface. Even though the DNA remaining after DNases treatment is likely to be almost entirely encapsidated, as a precautionary measure we preferred to use the term "DNase protected. Regarding DNA extraction from rAAV productions, we decided to avoid the use of silica column, known to induce size selection bias and possible DNA contaminations (Evans GE et al, J Clin Microbiol. 2003 Jul;41(7):3452-3.). Instead, we took advantage of a simple procedure based on a modified salting-out precipitation method (Gentra-Puregene blood kit, Qiagen, Venlo, Limburg, Netherlands) and obtained an average yield of rAAV DNA extraction between 50% and 90%.
Since current NGS technologies require a double stranded DNA (dsDNA) input for library preparation, the single stranded rAAV genome had to be converted into dsDNA in vitro (Fig.1c) . We developed a robust method relying on random priming and DNA Polymerase I with inherent 3'→5' and 5'→3' exonucleases activities. The efficiency of second strand synthesis was controlled by incorporating fluorescein-labelled dUTP (Fig.S2) . Although a smear of labelled DNA can be observed on Southern immunoblotting, a strong band is visible at the expected rAAV genome size (Fig.S2a) . The smear indicates a partial fragmentation during the second strand synthesis. Then, the fluorescence intensity was quantified using a fluorescence plate reader (VictorX3, Perkin Elmer, Waltham, MA, USA) and normalized by the mass of DNA in each sample (Fig.S2b ). All the samples were detected above the negative control, with intensities comparable to the positive control.
Since this protocol might skew relative sequence representation, ratios of rAAV genome copies per plasmid backbone copies were determined using qPCR before and after the second strand synthesis (Fig.S3 , Table S9 ). They did not show significant sequence enrichment during this critical step of the protocol.
Lastly, we performed an adapted procedure for NGS library preparation from Kozarewa et al (Kozarewa and Turner, J Clin Microbiol. 2003 Jul;41(7):3452-3). The samples were sheared by sonication in fragments with a median size of 300 bp, end repaired, A-tailed and adapters were ligated. One of the 2 adapters contains a short DNA barcode, also called index, which is different for each experimental sample. These fragments were amplified by PCR using the PfuUltra II Fusion polymerase (Fig.1d) . To remove the smallest fragments and the dimers of adapters, each step was followed by a gel free size-selection (SPRIselect, Beckman Coulter, Indianapolis IN, USA). Libraries were controlled after sonication and PCR steps by electrophoresis on Agilent 2100 Bioanalyzer (Fig.S4 ). We obtained PCR products centered on 400 bp (range 250 to 1000 bp) confirming that the upstream steps were correctly performed. Finally, samples were quantified and pooled in equimolar quantities. We also add 1 to 5% of Phi-X DNA in the mix to increase sequence diversity for Illumina Sequencing to compensate the high redundancy of the dataset.
High throughput sequencing was achieved on an Illumina HiSeq platform (Rapid Run, 2 × 101pb).
II) Production, purification and characterization of rAAV vectors
We produced an rAAV 2/8 CMVp-eGFP-hygroTK-bGHpA raw batch by transient transfection of adherent HEK-293 cells and purified it either by cesium chloride density gradient (CsCl), affinity chromatography (AVB) or ion exchange chromatography (IEX) (Fig.S5 ). Recombinant AAV preparations were characterized with standard quality controls methods, including extensive qPCR analyses (Table S9) .
To determine the protein purity of rAAV productions, SDS-PAGE followed by Coomassie blue and silver staining were performed. For all batches, protein purity was higher than 90% as determined using GeneTools software from Coomassie blue staining gel (Fig.S6a ). However, particles purified by AVB chromatography contained more contaminants (lipids, nucleic acids, glycans or proteins) as shown by silver staining (Fig.S6b ). In addition, the Coomassie blue staining suggests that rAAV purified by AVB contains more empty particles, as confirmed by an AAV8 titration ELISA (Fig.S6c ). This is likely to be due to the inability of AVB columns to differentiate between full, malformed and empty particles, while the IEX and CsCl purifications used in this work can enrich in full rAAV particles.
Quantification of the DNA composition by qPCR (Table S1 ) showed that rAAV particles purified by CsCl were less contaminated by the vector plasmid and, to a lesser extent, by the helper plasmid, compared with both chromatographic methods. Altogether, these results emphasize the impact of the purification process on the quality of rAAV batches.
III) Development and validation of ContaVect
A dedicated bioinformatics pipeline (ContaVect) was developed to attribute each sequencing reads to its most likely original sequence (Fig.1e ). Users can provide several reference sequences for the rAAV genome and the possible DNA contaminants (vector plasmid, helper plasmid, human genome…). If several reference sequences have homologies, it can results in the misattribution of sequencing reads, and/or bad quality mapping, as shown thanks to an artificial dataset mimicking an rAAV production (CMVp-eGFP-hygroTK-bGHpA) in Table S3 .
Indeed, without any preprocessing of the reference sequences we obtained low sensitivity (true positive rate) and specificity (true negative rate) scores for some of the references (< 50%). We developed a fast reference preprocessing module integrated into ContaVect to identify homologies with Blast algorithm and mask them in the less frequent reference, based on a ranking of estimated relative abundance provided by the user. With the preprocessing module, we obtained a much better sensitivity (90.9%, to 100%) and specificity (99.7% to 100%) ( intensities of rAAV preparations quantified using Perkin Elmer Victor X3 in the 6 experimental samples described in the manuscript. Results were normalised by converting the number of copies after second strand synthesis obtained by qPCR into total DNA mass. The positive control is the same than in (a) and the negative control is a plasmid fragment containing the rAAV genome that underwent the protocol but without DNA Pol I.
Figure S3. Selection bias induced by second strand synthesis
To evaluate the possible selection/amplification bias due to the second strand synthesis, we calculated a ratio between the rAAV genome copy number and vector plasmid copy number, in process before and after this critical step. The rAAV genome and vector plasmid copy numbers were determined using qPCR targeting the bGH polyadenylation signal (Table S9 , BGH pA) and the kanamycin resistance gene (Table S9 , Kana R), respectively.
No significant difference was found for all experimental samples when comparing the ratio before and after second strand synthesis. Horizontal lines represent the medians. n=6 for each rAAV2/8-CMVp-eGFP-hygroTK-bGHpA samples. n=2 for the internal normalizer and the control. Statistics: two tailed Mann-Withney's U-test, Confidence interval = 95%.
Figure S4. Distribution of DNA fragment sizes after NGS library preparation
The distribution of DNA fragment sizes was determine at the end of the NGS library preparation protocol by the Agilent 2100 Bioanalyzer system using High sensitivity DNA chip. As showed for each of the 6 rAAV sample libraries prepared for this study, fragments below 250 bp were eliminated by the successive washing steps. 
Figure S6. Characterization of rAAV productions purity and titer
The protein purity of rAAV preparation purified by IEX, CsCl and AVB methods was evaluated by running SDS-PAGE gels and staining with (a) Coomassie blue (1×10 11 vector genomes/sample) or (b) silver staining (2×10 10 vector genomes/sample). kD: BenchMark protein ladder in kiloDalton (Invitrogen) (c) The overall protein purity was determined using Coomassie blue staining and the vector particle titer was evaluated using an anti-AAV8 capsid ELISA assay. rAAV productions were titered by qPCR targeting different sequences present in the rAAV genome. DNA contaminants from the vector plasmid backbone, the helper plasmid and the human genome were quantified using sequence specific targets. Similar to the SSV-Seq protocol, encapsidated and non-encapsidated targets were differentiated by our DNases treatment. The quantity of each target was expressed in copy number per mL of final rAAV product. For human genome, the copy number was below our limit of quantification in all of the conditions (3x10 3 copies/mL). Confusion Matrix and mapping prediction rates were obtained with an artificial dataset mimicking an rAAV production CMVp-eGFP-hygroTK-bGHpA generated using Fastq Control Sampler.
SUPPLEMENTARY TABLES
Upper table.
Reads from rAAV, Backbone, Helper, Ad5, Human references were generated from the reference fasta sequences (see material and method section) and the read from the "unmapped" reference from a randomly generated sequence. The numbers of reads generated per reference are indicated in the lower row in the corresponding columns. The last columns summarize the number of read attributed to each reference after mapping with ContaVect, without the reference pre-processing module. A green cell indicates a correct assignation, while a red cell corresponds to mapping errors.
Lower Confusion Matrix and mapping prediction rates were obtained with an artificial dataset mimicking an rAAV production CMVp-eGFP-hygroTK-bGHpA generated using Fastq Control Sampler.
Reads from rAAV, Backbone, Helper, Ad5, Human references were generated from the reference fasta sequences (see material and method section) and the read from the "unmapped" reference from a randomly generated sequence. The numbers of reads generated per reference are indicated in the lower row in the corresponding columns. The last columns summarize the number of read attributed to each reference after mapping with ContaVect, using the reference pre-processing module. A green cell indicates a correct assignation, while a red cell corresponds to mapping errors.
Lower The number of reads assigned by ContaVect to each reference, including technical decoy references and unmapped reads, is indicated for the 2 technical replicates of each sample. The size of references in base pairs (bp) is indicated in the second column of the table. The number of reads found in a specific locus of chr15 (not disclosed due to confidentiality concerns) and in the Dloop of mtDNA (human genome GRCh38 MT: 16, 561) , is indicated in the 2nd and 3rd columns of the table for the 2 technical replicates of each sample. The 4th and 5th columns contain the percentages of the reads compared with all of the reads found in the human genome, and the 2 last columns the percentage compared with all of the reads mapped, regardless of the reference. Red cells represent samples for which there is a higher contamination. 5': 5' DNA end, 3': 3' DNA end, *: phosphorothioate linkage, P: phosphorylated end.
P7 adapter contains a six bases index used to identify samples after multiplexing (NNNNNN in P7 sequence), as described by Illumina. The table summarizes the indexes used for the 2 replicates of each samples. Indexes were randomized between the two SSV-Seq runs to avoid eventual index sequence bias.
SUPPLEMENTARY MATERIAL AND METHODS rAAV vectors production and purification
All of the vectors were manufactured and characterized at INSERM UMR 1089 Vectors Production Core (Nantes, France), except for the Immune affinity chromatography step, which was performed at Genethon (Evry, France).
Vectors production
The rAAV 
Cesium Chloride (CsCl) gradients ultracentrifugation purification
The crude bulk was clarified by centrifugation, precipitated with a polyethylene glycol (PEG), treated with
Benzonase Nuclease (Merck-Millipore) and purified by double Cesium Chloride gradient (CsCl) for enrichment in full particles, as extensively described in Ayuso et al, 2010, Gene Ther. 17: 503-510.
Ion-exchange chromatography (IEX) purification
The crude bulk was clarified by filtration using Millipore Opticap XL2 Polysep disposable capsule filters (Merck-Millipore), and purified by three successive ion exchange chromatography steps:
 An anionic membrane, Mustang® Q XT Ion Exchange Chromatography Capsules (Pall Corporation). The clarified bulk was loaded with 20mM Tris buffer to reduce salinity to 40 mM and adjusted to pH 8.0 to capture the rAAV vector particles and then eluted with increasing concentration of 300 mM NaCl  A multimodal weak cation exchanger XK26/20 column (GE Healthcare Life sciences). The previously eluted volume was loaded with 50mM MES buffer to reduce salinity to 30 mM and adjusted to pH 6,0 to capture the rAAV vector particles and eluted with increasing concentration of 600 mM NH4Cl
 An anionic monolith columns CIMmultus QA 80ml (Bia Separations). The previously eluted volume was loaded with 20mM Tris buffer to reduce salinity to 40 mM and adjusted to pH 8.5 to capture the rAAV vector particles and then eluted with increasing concentration of 300 mM NaCl All three columns were already used several times for rAAV purification before this study, but were sanitized prior usage with the following protocol: 2 to 3 column volumes (CV) of water, incubation with 1N NaOH for 30 to 60 min, 2 to 3 CV of water, 5 to 10 CV of Tris NaCl buffer, 2 to 3 CV of water, 5 to 10 CV of EtOH 20%.
Immune affinity chromatography purification
The crude bulk was clarified by centrifugation, treated with Benzonase Nuclease (Merck-Millipore) and purified by immune affinity chromatography with a single AVB Sepharose High Performance column (GE Healthcare Life sciences) as described in Smith et al, 2009 , Mol. Ther. J. Am. Soc. Gene Ther. 17: 1888 -1896 Similar to IEX chromatography, the column was already used several times for rAAV purification before this study, but was sanitized prior usage with the following protocol: 2 to 3 column volumes (CV) of water, incubation with 0.1M H3PO4 (phosphoric acid) + 1M NaCl for 20 min, 2 to 3 CV of water, 5 to 10 CV of PBS buffer, 2 to 3 CV of water, 5 to 10 CV of EtOH 20%.
Concentration and formulation
The three rAAV batches obtained by CsCl, IEX and AVB purifications were concentrated by tangential flow filtration (TFF) with a 100 kDa molecular weight cut-off (GE Healthcare). The concentrated vectors were formulated in Dulbecco's phosphate-buffered saline (Lonza, Verviers, Belgium) containing 0.001% Pluronic F-68 (Gibco/Life Technologies).
Comparative efficacy of DNases DNase treatment
Samples were treated with 20U of DNase I (Roche, Basel, Switzerland), 10U of TurboDNase (Life Technologies, Carlsbad, CA, USA), 250U of Benzonase (Merck, Billerica, MA, USA) or a mix of 4U of PlasmidSafe (PS) and 10U of Baseline-ZERO (BL). They were incubated 2 hours at 37°C in a final volume of 200µL containing the buffers recommended by each manufacturers or an optimized buffer for our DNases mix (Baseline ZERO buffer, supplemented with 1mM of ATP). The reaction was stopped with 3mM of EDTA 30min at 75°C.
Quant-iT PicoGreen quantification
A working solution of the Quant-iT PicoGreen dsDNA reagent (Life technologies) was prepared by diluting the concentrated DMSO solution 400-fold in TE. Samples and phage-λ DNA stock solution were diluted in TE buffer (10mM Tris-HCl, 1mM EDTA, pH 7.5) to a final volume of 10 µL before the addition of 90 µL of the working solution. After 5 minutes at room temperature, protected from light, fluorescein intensities were quantified using a fluorescence plate reader (VictorX3, Perkin Elmer). DNA concentration of each sample was determined from the standard curve generated by phage-λ dilutions.
Quality controls of rAAV productions Particle titer
The particles concentration was determined using the Progen AAV8 Titration ELISA kit (Progen Biotechnik GmbH, Heidelberg, Germany) according to the manufacturer's instructions.
Vector genome and DNA contaminants quantification
Each rAAV vector was treated with 4U of Plasmid-Safe and 10U of Baseline-ZERO for 2h at 37°C. The reaction was stopped with 3mM of EDTA for 30 min at 75°C. DNA extraction was carried out using the High Pure Viral Nucleic Acid kit (Roche). Then, the vector genome concentration was determined by Taqman qPCR targeting the ITRs (ITR2), the transgene (GFP1 and GFP2), the promoter (CMVp) or the polyadenylation signal (bGHpA).
DNA contaminants were also quantified by qPCR targeting plasmid backbone (KanaR), helper plasmid (cap8, rep2
and E4) and human genome (human ALB1). qPCR reactions were performed with the StepOne Plus Real-time PCR system (Life Technologies) in a final volume of 20µL using the Premix Ex Taq kit (Takara Bio Inc., Otsu, Japan).
Conditions for each reaction are detailed in Table S9 , following MIQE guidelines (Bustin,S.A. et al. (2009) . Clin.
Chem., 55, 611-622.).
Protein purity and identity
The purity and identity were evaluated by SDS-PAGE, using Coomassie Blue (Imperial TM Protein Stain, Thermo Fisher Scientific Inc., Waltham, MA, USA) and silver staining (PlusOneTM Silver Stain kit, Protein, GE Healthcare, Little Chalfont, United Kingdom) according to the manufacturer's recommendations. The purity relative to non-vector impurities visible on stained gels was determined using GeneTools (Syngene, Frederick, MD, USA).
In process NGS libraries preparation controls
Controls of second strand synthesis
A reaction containing ¼ fluorescein-12-dUTP and ¾ dTTP (Thermo Fisher Scientific Inc.), instead of dTTP alone, was performed similar to the protocol described in the manuscript material and methods. The mix was then purified using NucleoSpin®Gel and PCR Clean-up kit (Macherey-Nagel) and the fluorescence intensity was quantified using Victor X3 (Perkin Elmer).
DNA quantification
Aliquots were sampled after each major step of SSV-Seq protocol, (1) after the proteinase K treatment, (2) after the rAAV DNA extraction and (3) after the double strand synthesis purification. From these samples, rAAV genomes and plasmid backbone contaminants were quantified by Taqman qPCR targeting BGHpA sequence and KanaR sequence, respectively.
